Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzyme
- 30 June 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (6) , 613-618
- https://doi.org/10.1016/s0960-894x(01)81209-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.The Journal of Experimental Medicine, 1991
- A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbitsThe FASEB Journal, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 ReceptorScience, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Identification of a monocyte specific pre-interleukin 1 beta convertase activity.Proceedings of the National Academy of Sciences, 1989
- Activation of interleukin‐ 1β by a co‐induced proteaseFEBS Letters, 1989
- Selective cleavage of the allyl and (allyloxy)carbonyl groups through palladium-catalyzed hydrostannolysis with tributyltin hydride. Application to the selective protection-deprotection of amino acid derivatives and in peptide synthesisThe Journal of Organic Chemistry, 1987
- Oxidation of long-chain and related alcohols to carbonyls by dimethyl sulfoxide "activated" by oxalyl chlorideThe Journal of Organic Chemistry, 1978